Blood Glucose Monitoring Devices Market Analysis

  • Report ID: 4606
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Blood Glucose Monitoring Devices Market Analysis

Product (Self-Monitoring Devices, Continuous Glucose Monitoring Devices)

The global blood glucose monitoring devices market is segmented and analyzed for demand and supply by product into self-monitoring devices, and continuous glucose monitoring devices. Out of these two types of segments, the self-monitoring devices segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the ease of use provided by these devices as people can monitor their blood sugar levels through these devices in the comfort of their homes.  Further, the development of novel lancet devices with faster outcomes and less pain for the user is also anticipated to fuel market expansion. For instance, in November 2021, Intuity Medical, Inc., launched the POGO Automatic Monitor, an innovative automatic glucose monitoring device. It utilizes ten-test cartridges that include test strips and lancets instead of depending on separate test strips and lancets. At the touch of a button, the POGO Automatic instantly lances, gathers blood, and provides results in a few seconds.

Disease Type (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes)

The global blood glucose monitoring devices market is also segmented and analyzed for demand and supply by disease type into type 1 diabetes, type 2 diabetes, and gestational diabetes. Amongst these three segments, the type 2 diabetes segment is expected to garner a significant share, backed by the rapidly surging prevalence of type 2 diabetes patients throughout the world. As per the World Health Organization report, type 2 diabetes accounts for more than 95% of all diabetes cases worldwide. This, as an outcome, is projected to generate numerous opportunities for the growth of the segment in the coming years.

Our in-depth analysis of the global market includes the following segments:

                     By Product

  • Self-Monitoring Devices
  • Continuous Glucose Monitoring Devices

                      By Modality

  • Wearable
  • Non-Wearable

                      By Disease Type

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes

                     By Distribution Channel

  • Hospitals
  • Retail Sales
  • Homecare
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4606
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of blood glucose monitoring devices is estimated at USD 20.82 billion.

The blood glucose monitoring devices market size was valued at USD 19.31 billion in 2024 and is expected to cross USD 64.98 billion by the end of 2037, expanding at more than 9.7% CAGR during the forecast period i.e., between 2025-2037. Increasing perforation of continuous blood glucose monitoring (CGM) devices, rising ubiquity of diabetes, and growing investment in diabetic research activities will boost the market growth.

North America industry is poised to dominate largest revenue share by 2037, due to rising cases of diabetes with the prevalence of obesity owing to an inactive lifestyle in the region.

The major players in the market include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Ascensia Diabetes Care Holdings AG, Dexcom, Inc., NIPRO CORPORATION, Prodigy Diabetes Care, LLC, ACON Laboratories, Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample